BioCentury
ARTICLE | Company News

Avila, Celgene deal

March 12, 2012 7:00 AM UTC

Celgene completed its acquisition of Avila for $350 million in cash, plus up to $575 million in milestones. The milestones comprise up to $195 million related to the development and approval of Avila'...